| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $172.50M | $90.89M | $41.76M | $36.53M | $50.47M |
| R&D | $154.22M | $73.28M | $27.67M | $24.25M | $38.40M |
| SG&A | $18.27M | $17.61M | $14.09M | $12.28M | $12.07M |
| Operating Income | -$172.50M | -$90.89M | -$41.76M | -$36.53M | -$50.47M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$165.67M | -$80.60M | -$36.95M | -$35.35M | -$50.64M |
| EPS (basic) | – | -1.3200 | -0.8400 | -1.3700 | -2.9500 |
| EPS (diluted) | – | -1.3200 | -0.8400 | -1.3700 | -2.9500 |
| Shares (diluted) | – | $61.26M | $43.90M | $25.76M | $17.16M |